Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study.

M MahendraAbhishek NuchinRanjith KumarS ShreedharMahesh Padukudru Anand

Published in: Advances in respiratory medicine (2021)

Severe COVID-19 pneumonia is associated with very high mortality, especially in a resource-constrained setting. The use of remdesivir may have to be considered early in the course of disease to prevent excess mortality related to COVID-19.

Keyphrases

coronavirus disease
sars cov
cardiovascular events
risk factors
early onset
respiratory syndrome coronavirus
type diabetes
cardiovascular disease
intensive care unit
drug induced